Erin Johansson

5PUBLICATIONS
12CO-AUTHORS
Pharmaceutical delivery technologiesEpidemiological modellingPharmacogenomicsFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 29, 2026
Indirect Comparative Efficacy and Safety of Tirzepatide Versus Oral Semaglutide for the Treatment of Overweight and Obesity.

|Apr 23, 2026
Enhancing economic modelling in obesity: integrating novel type 2 diabetes progression & obstructive sleep apnea remission - a UK case study.

|Apr 21, 2026
Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trial.

|Mar 13, 2026
Comparison of Clinical Efficacy and Safety of Tirzepatide, Liraglutide and Semaglutide in Patients with Obesity and Without T2D: A Bayesian Network Meta-Analysis of Randomised Controlled Trials.

Andreea Ciudin, Helene Sapin, Ludi Fan

|Aug 11, 2025
Cost-Effectiveness of Tirzepatide Versus Liraglutide, Both Adjunct to Diet and Exercise, for Patients with Obesity or Overweight: A UK Perspective.

Matthew Capehorn, Erin Johansson, Alun Davies

Pageof 1

Frequent Collaborators

2 joint publications

Andreea Ciudin

2 joint publications

Helene Sapin

2 joint publications

Ludi Fan

2 joint publications

Georgios K Dimitriadis